Treatment for mold exposure depends on what the mold is actually doing to your body. For most people, that means managing allergic symptoms with medications you may already recognize: nasal steroids, antihistamines, and avoidance of the source. For a smaller group with more complex inflammatory reactions, treatment can involve binding agents, hormone support, and a longer recovery timeline. The first step in every case is figuring out which category you fall into.
How Doctors Evaluate Mold Exposure
There is no single test that confirms “mold illness.” Instead, doctors piece together your history, symptoms, physical exam findings, and selective lab work. The CDC advises that clinical evaluation of suspected mold-related illness should follow conventional clinical guidelines, and that no immunodiagnostic test should be used as the sole basis for diagnosis.
If your doctor suspects a mold allergy, the two standard tests are a skin prick test and a blood test measuring immunoglobulin E (IgE) antibodies. In a skin prick test, tiny amounts of common mold extracts are placed on your arm or back through small punctures. If you’re sensitized, a raised bump appears at the site. Blood tests measure IgE antibodies specific to mold species. A value of 0.35 kUA/L or higher for a mold mixture panel indicates sensitization. In one study of people exposed to water-damaged buildings, 41% showed elevated mold-specific IgE compared to 17% of unexposed individuals.
If results are positive for the general mold panel, your doctor may order follow-up testing for individual species to narrow down exactly which molds trigger your immune response. In cases where mold-induced asthma is suspected, the workup can extend to a bronchial challenge test, where you inhale a controlled amount of the suspected allergen while your lung function is monitored.
One test to be cautious about: urine mycotoxin panels sold directly to consumers. The CDC has noted there is no FDA-approved urine test for mycotoxins, and mycotoxin levels that predict disease have not been established. These tests may detect trace amounts of mold byproducts, but that alone doesn’t tell you whether those levels are causing your symptoms.
Treating Mold Allergies
Mold allergy treatment looks a lot like treatment for other environmental allergies. The first priority is reducing your exposure, whether that means remediating the mold in your home, improving ventilation, using HEPA air filters, or in some cases relocating. No medication works well if you’re still breathing in the thing causing your symptoms every day.
For symptom control, doctors typically prescribe nasal corticosteroid sprays to reduce inflammation in your nasal passages, along with oral antihistamines for sneezing, itching, and congestion. If you have mold-triggered asthma, treatment follows standard asthma guidelines: inhaled corticosteroids as a controller medication, with a rescue inhaler for flare-ups. These are the same medications used for any allergic asthma, adjusted based on severity.
Allergy immunotherapy (allergy shots) is an option for people whose symptoms don’t respond well to medications. This involves gradually increasing doses of the mold allergen over months to years, training your immune system to tolerate it. It’s not a quick fix, but it can provide lasting relief for some people.
Allergic Fungal Sinusitis
Some people develop a more stubborn condition called allergic fungal rhinosinusitis, where thick, sticky mucus packed with fungal debris fills the sinuses. This often requires endoscopic sinus surgery to physically remove the buildup and open the sinus passages. After surgery, doctors recommend oral steroids and topical nasal steroid sprays to prevent recurrence. A review of the available evidence found these two approaches have the strongest support for keeping symptoms from coming back.
For cases that don’t respond to standard treatment, doctors may consider oral antifungal medications, non-standard topical steroid delivery (such as steroid-containing sinus rinses), or immunotherapy. Topical antifungal rinses and leukotriene-blocking medications are sometimes tried, but there isn’t enough clinical data to make firm recommendations about them.
The CIRS Approach for Chronic Symptoms
A subset of patients experience persistent, multi-system symptoms after mold exposure: fatigue, brain fog, joint pain, shortness of breath, headaches, and light sensitivity, among others. Some practitioners diagnose this as Chronic Inflammatory Response Syndrome (CIRS), a condition originally described by Dr. Ritchie Shoemaker. CIRS remains controversial in mainstream medicine, but there is a growing body of clinical literature examining its diagnosis and treatment.
The diagnostic framework for CIRS looks at a broader set of biomarkers than standard allergy testing. Doctors check for elevations in inflammatory markers like TGF-beta 1, C4a, and MMP-9, along with reductions in regulatory hormones. They may also look at visual contrast sensitivity, a simple eye test that measures your ability to distinguish between shades of gray, which tends to be impaired in people with biotoxin-related illness. A formal case definition requires confirmed exposure to a water-damaged building, symptoms across multiple body systems, abnormalities in objective lab parameters, and the absence of other explanations for the symptoms.
Removing the Source
The first and most critical step is getting away from the mold. This usually means professional environmental testing, professional remediation of the affected space, replacing contaminated belongings like furniture and clothing that can harbor spores, and sometimes temporarily or permanently moving out of the building. Treatment rarely works if ongoing exposure continues.
Binding Agents
The central medication in the CIRS protocol is cholestyramine, a prescription bile acid binder originally developed to lower cholesterol. When taken on an empty stomach, it binds to biotoxins in the small intestine and prevents them from being reabsorbed into the bloodstream. The bound toxins are then eliminated through stool. The standard protocol calls for 9 grams mixed with water or juice, taken four times daily.
The most common side effects are gastrointestinal: bloating, constipation, and nausea. These are generally manageable and tend to improve over time. For people who can’t tolerate cholestyramine, colesevelam (a similar bile acid binder in pill form) is used as an alternative, though practitioners consider it roughly 25% as effective. Despite their popularity in some alternative health circles, activated charcoal, clay-based binders, and herbal detox products have not shown clinical benefit in published data from this protocol.
Additional Steps
After the binding phase, the CIRS treatment protocol moves through a series of additional steps targeting specific hormonal and inflammatory abnormalities found on lab testing. These can include nasal sprays to address colonized mold in the sinuses, hormone support for disrupted antidiuretic hormone or cortisol regulation, and in later stages, vasoactive intestinal peptide (VIP), a compound available only through compounding pharmacies. Most steps in the protocol are relatively affordable, with monthly costs of around $100 or less for each medication, though VIP is a notable exception as it isn’t covered by insurance.
The Role of Gut Health
Mycotoxins can disrupt the balance of bacteria in your gut, which has led researchers to investigate probiotics as a supportive measure during treatment. In one human study, participants taking a specific probiotic blend showed up to a 55% reduction in urinary markers of aflatoxin (a common mycotoxin) by the fifth week compared to placebo. Other studies have found that certain Lactobacillus strains reduce measurable mycotoxin levels in the blood. The mechanism appears to be direct binding: probiotic bacteria physically attach to mycotoxin molecules in the gut, reducing the amount your body absorbs.
This research is promising but still early. No major medical guidelines currently list probiotics as a standard mold treatment. That said, they carry minimal risk, and some doctors recommend them as part of a broader gut-restoration strategy alongside primary treatment.
Invasive Fungal Infections
In people with severely compromised immune systems, such as those undergoing chemotherapy or organ transplants, mold exposure can lead to invasive fungal infections where mold actually grows in lung tissue, sinuses, or other organs. This is a different situation entirely from allergic reactions or chronic inflammation, and it requires aggressive treatment with prescription antifungal medications.
Treatment duration depends on how well the infection responds, where it’s located, and which mold species is involved. Infections that form cavities in the lungs, reach the brain or bones, or involve drug-resistant species often require extended courses of antifungals lasting months. These patients need close monitoring by infectious disease specialists throughout treatment. For most people searching about mold exposure, this scenario is unlikely, but it underscores why immunocompromised individuals need to take mold exposure especially seriously.